EN DE
Watch India Glycols Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

India Glycols Limited (INDIAGLYCO) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of India Glycols Limited stock ₹325, price ₹311, upside +4.5%, quality 31 out of 100. Rating: fairly valued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials IN · ISIN INE560A01015

IG India Glycols Limited logo Some data Nov 14, 2026

India Glycols Limited

INDIAGLYCO · NSE

Cheap enough by our rule, but weak company and falling price: meets 1 of 3 rules.

Get notified free when this changes
Low debt 
Ranks above peers (10/13) 
Costs just 6.3 times its yearly profit. 
Fair value ₹325.38 · Fairly valued 
Expensive Growth (revenue 5y +12.9 %/yr in INR) 
Thin margins · 7.4% net margin (TTM) 
Some data 
Peak profit dampened: ₹637.62 → ₹325.38 
Quality 31/100 
Falling price (downtrend) 
Negative free cash flow 
Narrow moat 42/100 · thin data
⟳ Cyclical⚠ Dilution
Watch India Glycols Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹1,203 ₹236.20 Fair Value ₹325.38 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.

How to read this chart

60‑month range ₹236.20 – ₹1,203 · fair‑value band ₹227.76 – ₹422.99 · the ₹311.30 price screens below the ₹325.38 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.

Follow India Glycols in your weekly email

Every Wednesday you see whether India Glycols is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. It operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segments.

Show moreShow less

The company offers bio mono ethylene, di ethylene, and tri ethylene glycols; ethyl/butyl glycol ethers and acetates, and brake fluids; bio-polymers comprising guar and natural gums; biofuels; specialty chemicals, such as plasticisers, oil fields chemicals, bio-amines, methyl soyate, MDEA and MDEA derivatives, bio-potash granules, and C-Smart specialty products; molasses and grain based extra neutral alcohol; and specialty gases, including industrial and medical oxygen, food grade and industrial carbon dioxide, liquid argon and nitrogen, ethylene oxide, and bio ethylene oxide.

It also provides Indian made foreign liquor, such as whiskey under Soulmate Blu and Single Reserve brands; vodka under Amazing brand; and rum under Zumba and Beach House XXX brands, as well as economy spirits under Bunty brand, and branded country liquor.

In addition, the company offers natural active pharmaceutical ingredients, nutraceuticals, standardized botanical extracts, and nicotine derivatives.

Further, its products find applications in pharma and healthcare; textiles; automotive; personal care; industrial and manufacturing; paints and coatings; oil and gas; food ingredients; packaging; potable spirits; and other various industries. The company also exports its products.

The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India.

Stock analysis

India Glycols Limited (INDIAGLYCO) currently trades at ₹311.30, while our model-based Fair Value estimate is ₹325.38, so the stock looks roughly fairly valued today (gap 4.3%).

Show more

Valuation

Bull case: the Multiples group reads highest at a median of ₹742.53 per share, and 13 of the 16 models we run sit above the ₹311.30 price.

Bear case: the Dividend Discount group reads lowest at ₹112.39, and 3 of the 16 models stay below the price. Data coverage for this calculation is medium.

Scenario range: ₹227.76 (bear) to ₹422.99 (bull), the price of ₹311.30 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 31/100 (below-average quality), in the Basic Materials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

India Glycols Limited reported revenue of ₹42.1B in FY2026 versus ₹28.7B in FY2022, a compound +10.1%/yr. Reported net income was ₹2.9B in FY2026, compounding −3.7%/yr from FY2022.

Key figures

Market cap ₹20.9B (≈ $222M) Micro · P/E ratio 6.3 · P/S ratio 0.49 · EPS (TTM) ₹49.39 · Dividend yield 3.4% · Net margin 7.4% · Return on equity 11.3% · Return on assets (EBIT) 8.1% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The share trades about 74% below its 52-week high and 32% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −24% fair-value upside, at 5%, INDIAGLYCO screens cheaper than that median.

Fair Value models

Bear ₹227.76 Fair Value ₹325.38 Bull ₹422.99
Price ₹311.30 · Upside +4.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (₹31.12 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income ₹334.21 ₹347.32 ₹387.13 76
EPV ₹268.24 ₹311.34 ₹345.66 74
ROIC Compounder ₹268.24 ₹311.34 ₹345.66 72
All 16 models by family
Earnings-Based
Graham-Dodd ₹297.01 ₹1,141 ₹1,546 64
Lynch FV ₹347.70 ₹496.71 ₹645.72 61
PEG = 1.0 ₹347.70 ₹496.71 ₹645.72 57
EPV ₹268.24 ₹311.34 ₹345.66 74
Dividend Discount
Gordon GGM ₹71.60 ₹113.99 ₹142.63 69
DDM Multi-Stage ₹71.60 ₹110.79 ₹123.12 67
Multiples
P/E Multiple ₹556.90 ₹742.53 ₹928.16 63
P/S Multiple ₹556.90 ₹742.53 ₹928.16 58
P/B Multiple ₹984.01 ₹1,312 ₹1,640 55
EV/EBIT ₹528.87 ₹786.76 ₹1,045 65
EV/EBITDA ₹481.69 ₹723.85 ₹966.01 66
EV/Revenue ₹414.94 ₹697.68 ₹980.42 52
Asset-Based
NCAV (Graham) ₹218.67 ₹293.01 ₹437.34 54
Economic Profit
Residual Income ₹334.21 ₹347.32 ₹387.13 76
ROIC Compounder ₹268.24 ₹311.34 ₹345.66 72
Growth Earnings
Growth-Adj P/E ₹446.33 ₹637.62 ₹828.91 67

The fair value above starts from this blend and is adjusted for a cyclical peak year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 31/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 37
How much profit the company makes from its sales and capital
Quality Growth 50
Are margins and returns getting better?
Cashflow 40
Do the profits arrive as real cash?
Financial strength 38
Debt, balance sheet and risk of trouble
Investment 24
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 4
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 50/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+11.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.9%
Start year 2021 (pandemic). Over 10 years: +6.1% a year
Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.1%
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+5.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+1.6%
Dividend (yield on the price)3.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.1.6% vs 15.0%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 12%
Pace: the 5-year rate starts in 2021 (pandemic)

Watch INDIAGLYCO, get fair value alerts →

Compare India Glycols Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 358 stocks

Beats the industry median on 10/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 31 · Bottom 25%
Fair Value upside +4.5% · Above median
Profitability
Return on equity (12 months) 11.3% · Above median
Return on assets 4.5% · Above median
Net margin (12 months) 7.4% · Above median
Operating margin (12 months) 11.2% · Above median
Growth and dividend
Revenue growth (quarter YoY) 8.6% · Below median
Dividend yield (12 months) 3.4% · Above median
Balance sheet
Debt / equity 0.31× · Above median

Valuation Multiplesvs Chemicals median · lower = cheaper

P/E (12 months) 6.3× · Cheapest 25%
P/B 0.71× · Cheapest 25%
P/S (12 months) 0.49× · Cheapest 25%
EV/EBITDA 4.6× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)39 · sector 10
FUTURE (revenue growth)43 · sector 69
PAST (return on equity)45 · sector 23
HEALTH (low debt)84 · sector 94
DIVIDEND (yield)68 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

India Glycols Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "India Glycols Limited Fair Value". https://www.fairvalue-calculator.com/stock/INDIAGLYCO

Frequently asked questions

Is India Glycols Limited (INDIAGLYCO) overvalued or undervalued?
As of Nov 14, 2026, our model estimates a fair value of ₹325.38 versus a price of ₹311.30, about +5% upside (fairly valued).
What is the fair value of INDIAGLYCO?
Our model-based fair value for India Glycols Limited is ₹325.38 (as of Nov 14, 2026), built from audited fundamentals. The current price: ₹311.30.
What is the quality score of INDIAGLYCO?
India Glycols Limited has a Quality Score of 31/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for India Glycols Limited (INDIAGLYCO)?
Our model-based price target is the fair value of ₹325.38 (as of Nov 14, 2026) from 16 valuation models. Cautious scenario ₹227.76, optimistic scenario ₹422.99. It is a calculation from audited fundamentals, not an analyst target.
What is the India Glycols Limited stock forecast for 2026?
Our models put fair value at ₹325.38, about +5% upside versus a price of ₹311.30 (fairly valued). Cautious scenario ₹227.76, optimistic scenario ₹422.99. The calculation is refreshed regularly with new filings.
What is the revenue of India Glycols Limited (INDIAGLYCO)?
India Glycols Limited reported trailing-twelve-month revenue of about ₹43.0B (latest available figure, as of Nov 14, 2026).
Does India Glycols Limited pay a dividend?
India Glycols Limited currently shows a dividend yield of 3.38% relative to its recent price (as of Nov 14, 2026).
How much is the dividend of India Glycols Limited (INDIAGLYCO)?
India Glycols Limited has a dividend yield of 3.4%.
What is the intrinsic value of India Glycols Limited (INDIAGLYCO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For India Glycols Limited it is ₹325.38 per share (as of Nov 14, 2026), against a price of ₹311.30. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is India Glycols Limited stock overvalued or undervalued in 2026?
As of Nov 14, 2026, INDIAGLYCO trades below its calculated fair value: price ₹311.30, fair value ₹325.38, a gap of about +5% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of INDIAGLYCO?
No. The price is what the market pays today (₹311.30); the fair value is what the company's own numbers justify (₹325.38). For India Glycols Limited the two are ₹14.08 per share apart. That gap is exactly why we show both numbers side by side.
How much is India Glycols Limited worth?
The market values India Glycols Limited at about ₹20.9B (market capitalisation, as of Nov 14, 2026). Per share that is ₹311.30; our models calculate a fair value of ₹325.38 per share.
What do the bullish and bearish scenarios say about INDIAGLYCO?
Our models span a range for India Glycols Limited: cautious scenario ₹227.76, base ₹325.38, optimistic ₹422.99 per share (as of Nov 14, 2026, price ₹311.30). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of INDIAGLYCO?
India Glycols Limited trades at a price-to-earnings ratio of 6.3 (as of Nov 14, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹325.38 is built from several models across several years. Other multiples: P/B 0.7, P/S 0.5, EV/EBITDA 4.6.
How solid is the balance sheet of India Glycols Limited (INDIAGLYCO)?
Balance-sheet figures for India Glycols Limited (as of Nov 14, 2026): return on equity 11.3%, debt of 0.31 per unit of equity. They feed the Quality Score of 31/100, which measures business quality independently of the share price.
How far is INDIAGLYCO from its 52-week high?
India Glycols Limited trades at ₹311.30, about 74% below its 52-week high of ₹1,203 and 32% above the low of ₹236.20 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of ₹325.38 is for.
Which stocks are comparable to India Glycols Limited?
From the same area (Basic Materials) we also value BASF SE, Saudi Basic Industries Corporation, Dow Inc, Ningxia Baofeng Energy Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is India Glycols Limited stock attractive at the current price?
The data as of Nov 14, 2026: price ₹311.30, calculated fair value ₹325.38 (+5%), Quality Score 31/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of INDIAGLYCO calculated?
We run India Glycols Limited through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹325.38 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. India Glycols Limited currently trades 4% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of India Glycols Limited (INDIAGLYCO)?
The closing price on Nov 13, 2026 was ₹311.30. Our model-based fair value is ₹325.38, about +5% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with India Glycols Limited right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (₹227.76 to ₹422.99) leaves room in how you read the outcome.

Key figures of India Glycols Limited

How large is the market capitalisation of India Glycols Limited (INDIAGLYCO)?
The market capitalisation of India Glycols Limited is ₹20.9B (≈ $222M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of India Glycols Limited (INDIAGLYCO)?
The price-to-sales ratio of India Glycols Limited is 0.49 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of India Glycols Limited (INDIAGLYCO)?
Earnings per share at India Glycols Limited are ₹49.39 (price ÷ EPS = P/E 6.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of India Glycols Limited (INDIAGLYCO)?
The dividend yield of India Glycols Limited is 3.4% (payout 21.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of India Glycols Limited (INDIAGLYCO)?
The net margin of India Glycols Limited is 7.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of India Glycols Limited (INDIAGLYCO)?
The return on equity (ROE) of India Glycols Limited is 11.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of India Glycols Limited (INDIAGLYCO)?
On an EBIT basis the return on assets of India Glycols Limited is 8.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of India Glycols Limited (INDIAGLYCO)?
The operating margin of India Glycols Limited is 11.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at India Glycols Limited (INDIAGLYCO)?
Revenue at India Glycols Limited is growing 8.6% versus a year earlier (3y avg +16.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at India Glycols Limited (INDIAGLYCO)?
Earnings per share at India Glycols Limited are growing 22.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does India Glycols Limited (INDIAGLYCO) generate?
The free cash flow of India Glycols Limited is −₹1.7B (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does India Glycols Limited (INDIAGLYCO) carry?
The net debt of India Glycols Limited is ₹16.4B (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Why does India Glycols Limited meet the fair value rule although the fair value shown is lower?
Peak profit dampened: ₹637.62 → ₹325.38. The latest annual profit is far above the years before, and such peaks rarely last. So we calculate cautiously with ₹325.38 instead of ₹637.62. If the profit stays high, we ease the caution year by year. As in the backtest, the fair value rule checks the value before: +105% against the price.
Free · no account needed

Watch India Glycols Limited in the live analysis

One click puts India Glycols Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.